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Family History
of Heart Disease
The Re-Emergence
of a Traditional Risk Factor*
Themistocles L. Assimes, MD, PHD
Stanford, California
The familial aggregation of coronary artery disease (CAD)
was first noted in several relatively small epidemiological
studies performed in the 1950s and early 1960s (1). Some of
these early reports actually predated the identification of the
major “traditional” risk factors of CAD by Framingham
investigators. Thus, it was initially not clear what proportion
of the familial aggregation of CAD observed was simply a
consequence of the familial aggregation of traditional risk
factors.
See page 619
A number of larger case-control and cohort studies
followed in the 1970s and 1980s that unequivocally
established family history as an independent risk factor
for CAD (1). Through multivariate analyses, these stud-
ies also suggested that only a fraction of the familial
aggregation observed could be accounted for by the
familial aggregation of traditional risk factors of CAD.
Curiously, family history was not included in the original
Framingham risk profile published in 1976 and subse-
quently adopted by the influential Adult Treatment
Panels (2,3). The main reasons cited for omitting this
variable were its limited incremental predictive value over
other major risk factors and the challenge in measuring it
reliably. Consequently, as the Framingham risk score
became widely implemented in the 1990s, research fo-
cused on further defining the clinical utility of document-
ing a family history in the primary prevention of CAD
probably received less attention than it deserved. Instead,
scientists focused on estimating what proportion of the
unidentified factors responsible for familial aggregation
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Landmark adoption and twin studies concluded that this
proportion was substantial, especially among families
with early manifestation of disease (4,5).
Over the past 10 years, several other groups have devel-
oped cardiovascular disease risk scores for clinical use (6). In
urope, the SCORE (Systematic Coronary Risk Evalua-
ion) project has produced multiple country-specific risk
cores for fatal CAD, whereas the ASSIGN (Assessing
ardiovascular Risk to Scottish Intercollegiate Guidelines
etwork/SIGN to Assign Preventative Treatment) and
RISK (QRESEARCH Cardiovascular Risk algorithm)
rojects have produced risk scores for cardiovascular disease
CVD) among Scottish and English populations, respec-
ively. In the United States, the Reynolds risk score was
ecently developed in women and was subsequently also
emonstrated to be effective in a cohort of men. In contrast
o the Framingham cohort, family history was found to have
dequate incremental predictive value over other major
raditional risk factors in all 3 of the new scores where this
nformation was available.
In this context, the report by Chow et al. (7) in this issue of
he Journal is a timely one. This important INTERHEART
ubstudy documents, for the first time, the ability of a measure
f family history of CVD, in this case, parental history of
yocardial infarction (MI), to predict the risk of an important
dverse cardiovascular outcome, in this case nonfatal MI,
cross all major geographic regions and race/ethnic groups of
he world. Consistent with previous studies involving more
omogeneous populations, the excess risk conferred by a
arental history of MI was independent of all other traditional
isk factors, and its magnitude was related to the age at onset
f disease and the number of family members affected (1,5,8).
One finding of this study that may initially appear
nconsistent with previous studies was the limited attenua-
ion observed of the overall age-, sex-, and region-adjusted
dds ratio (OR) for parental history of MI after further
djustment for all INTERHEART risk factors (1,5,8). The
egree of attenuation is important because it indirectly
eflects the contribution of familial aggregation of tradi-
ional risk factors to the association between parental history
f MI and risk of MI. In this study, the point estimate of the
R after this full adjustment decreased from 1.81 to 1.74,
uggesting that this contribution is small. However, 3
onsequences of the case-control design of this study may
ave contributed to this seemingly muted degree of atten-
ation. First, no incident fatal cases could be enrolled.
revious prospective studies incorporating validated CVD
vents in first-degree relatives have demonstrated a generally
igher degree of attenuation of risk ratios among subjects
ith a family history of premature CVD and among subjects
ith a more severe outcome including early age of onset and
eath from CVD compared with other cases (5,8). In this
ontext, the larger degree of attenuation observed in
NTERHEART among cases with early onset MI, parental
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parents, or a combination thereof is reassuring. Second,
adjusting for hypertension status instead of a more accurate
pre-event blood pressure may have also led to a lesser degree
of attenuation of the OR. Last, the study produced some-
what unexpected relationships between parental history of
MI and several behavioral risk factors including smoking,
physical activity, and diet. These unexpected relationships
may have negatively affected the attenuation forces on the
OR by the biological risk factors.
Among a subset of cases and controls, the investigators
assessed the influence of a small number of genetic variants
previously found to be associated with CAD. These variants
collectively would be expected to attenuate the OR, yet no
attenuation was observed. The authors appropriately em-
phasize the power limitations of their genetic analyses given
the small number of variants used and the fact that most of
them influenced risk factors already included in the multi-
variate analysis. These genetic analyses are worth repeating
after expanding the genotyping effort in this sample set to all
variants that have been robustly associated with CAD and
its major risk factors through more recent genome-wide
association studies (9).
It will likely take several years and possibly decades before
cardiovascular epidemiologists are able to identify the nu-
merous genetic and nongenetic factors responsible for fa-
milial aggregation of heart disease. In the meantime, the
study by Chow et al. (7) combined with recent efforts to
develop new risk scores around the world have undoubtedly
reignited interest in understanding the role of this tradi-
tional risk factor in the primary prevention of CAD. In
developed countries, the predictive ability of a family history
probably improved over the past few decades in parallel with
an enhanced ability to diagnose heart disease and the
public’s increasing awareness of its causes and consequences.
In the future, the predictive ability of a family history may
further improve as linked electronic medical records facili-
tate the reliable identification of family members with
cardiovascular disease as well as traditional risk factors.
Finally, in developing countries around the world under-
going the epidemiological transition to chronic diseases, acrucial need to identify and treat people at risk of CAD
using cost-effective nonlaboratory-based risk scores has
emerged (10). Clearly, measures of familial risk as imple-
mented in this study have the potential to play an important
role in meeting this need and consequently substantially
reducing the global burden of cardiovascular disease.
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